- Home
- NERV vs EFOI Comparison
NERV vs EFOI Comparison
Compare NERV & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- EFOI
- Stock Information
- Founded
- NERV 2007
- EFOI 1985
- Country
- NERV United States
- EFOI United States
- Employees
- NERV N/A
- EFOI N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- EFOI Building Products
- Sector
- NERV Health Care
- EFOI Consumer Discretionary
- Exchange
- NERV Nasdaq
- EFOI Nasdaq
- Market Cap
- NERV 12.0M
- EFOI 12.6M
- IPO Year
- NERV 2014
- EFOI 1994
- Fundamental
- Price
- NERV $2.25
- EFOI $1.91
- Analyst Decision
- NERV Hold
- EFOI
- Analyst Count
- NERV 1
- EFOI 0
- Target Price
- NERV $5.00
- EFOI N/A
- AVG Volume (30 Days)
- NERV 35.1K
- EFOI 7.2K
- Earning Date
- NERV 08-14-2025
- EFOI 08-12-2025
- Dividend Yield
- NERV N/A
- EFOI N/A
- EPS Growth
- NERV N/A
- EFOI N/A
- EPS
- NERV 1.48
- EFOI N/A
- Revenue
- NERV N/A
- EFOI $4,233,000.00
- Revenue This Year
- NERV N/A
- EFOI N/A
- Revenue Next Year
- NERV N/A
- EFOI N/A
- P/E Ratio
- NERV $1.52
- EFOI N/A
- Revenue Growth
- NERV N/A
- EFOI N/A
- 52 Week Low
- NERV $1.15
- EFOI $1.14
- 52 Week High
- NERV $3.00
- EFOI $2.95
- Technical
- Relative Strength Index (RSI)
- NERV 69.92
- EFOI 39.61
- Support Level
- NERV $1.79
- EFOI $1.89
- Resistance Level
- NERV $1.81
- EFOI $2.08
- Average True Range (ATR)
- NERV 0.10
- EFOI 0.10
- MACD
- NERV 0.01
- EFOI -0.01
- Stochastic Oscillator
- NERV 76.56
- EFOI 5.56
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.